Clinical Trial Update: Persistence of Oral Tolerance to Peanut [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluating whether oral tolerance to peanut persists were posted in January 2017. The study enrolled participants with eczema and egg alle…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Egg Allergy
• Peanut Allergy

Drugs mentioned

• Peanut oral immunotherapy (peanut OIT)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Eczema, Egg Allergy | Phase 2 | Status: COMPLETED | Results posted: 2017-01-06